![](/img/cover-not-exists.png)
To induce or not to induce: Do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?
R. Higgins, J.K. Kirklin, R.N. Brown, B.K. Rayburn, L. Wagoner, R. Oren, L. Miller, M. Flattery, R.C. BourgeVolume:
24
Year:
2005
Language:
english
DOI:
10.1016/j.healun.2004.01.002
File:
PDF, 257 KB
english, 2005